Caredx Announces New Koar Data Linking Elevated Allosure® Kidney To Nearly 3-Fold Higher Risk Of Adverse Graft Outcomes In Patients With Borderline Rejection Or Tcmr At Asn Kidney Week 2026

By Reuters News

- CareDx, Inc. CDNA.O:

  • CAREDX ANNOUNCES NEW KOAR DATA LINKING ELEVATED ALLOSURE® KIDNEY TO NEARLY 3-FOLD HIGHER RISK OF ADVERSE GRAFT OUTCOMES IN PATIENTS WITH BORDERLINE REJECTION OR TCMR AT ASN KIDNEY WEEK 2026

Further company coverage: CDNA.O

Capital Com is an execution-only service provider. The present material must be regarded as marketing communication and should not be interpreted as investment research or investment advice. Any opinion that may be provided on this page does not constitute a recommendation by Capital Com or its agents. We do not make any representations or warranty on the accuracy or completeness of the information that is provided on this page. If you rely on the information on this page, then you do so entirely at your own risk